Lele S B, Piver M S, Matharu J, Tsukada Y
Department of Gynecologic Oncology, Roswell Park Memorial Institute Buffalo, New York 14263.
Gynecol Oncol. 1988 Oct;31(2):315-20. doi: 10.1016/s0090-8258(88)80010-6.
Between 1977 and 1986, 325 patients with a diagnosis of ovarian carcinoma, peritoneal cancer, or malignant mesothelioma were reviewed with identification of 23 patients (7%) having peritoneal papillary cancer. Only 2 patients had disease confined to the pelvis and the rest had widespread abdominal disease. Various combination chemotherapeutic agents were used with over a 65% response rate to first-line chemotherapy. Twenty of the 23 patients received cisplatin combination chemotherapy with an overall response rate of 65%.
